Skip to main content
OpenTrials
Completed

NCT Number: NCT05283642

D-chiro-inositol and Endometrial Thickness

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Endometrial Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Urogenital Diseases Uterine Diseases

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

ASL Umbria 2

Terni, Umbria, 05100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • altered endometrial thickness

Exclusion criteria

  • patients with cancer
  • patients under hormonal treatments (progestogens and/or estrogens)
  • patients supplemented with inositols

Treatment and study plan

DCI

Dietary Supplement

Oral supplementation with D-chiro-inositol once daily

Primary outcomes

  1. Change in endometrial thickness

    Time frame: Two time points: baseline and after three months

    Change in endometrial thickness by ultrasound measurement from baseline to three months

Sponsors and collaborators

Lead sponsor

Lo.Li.Pharma s.r.l

Industry

Registry information

Official study title

The Effects of D-chiro-inositol in Endometrial Thickness

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Mar 17, 2022
Registry last updated
Dec 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.